Animab
Latest round
- Series B
Last raised
- Jul 2025
Total raised
- $25M
Investors
- 8
About Animab
Based in the Flemish Region, Belgium, and founded in 2020 by scientific co-founders Vikram Virdi (Scientific Director), Ann Depicker, Nico Callewaert, Eric Cox, and Henri De Greve, Animab BV operates as a biotechnology company offering technology for generating monoclonal antibodies to livestock.
Who invested in Animab
8 investors across 4 rounds
See all investors in Animab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Animab
Who invested in Animab?
Animab has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Animab raised?
Animab has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Animab last raise money?
Animab's most recent round on record is a Series B, in Jul 2025.
What does Animab do?
Based in the Flemish Region, Belgium, and founded in 2020 by scientific co-founders Vikram Virdi (Scientific Director), Ann Depicker, Nico Callewaert, Eric Cox, and Henri De Greve, Animab BV operates as a biotechnology company offering technology for generating monoclonal antibodies to livestock.
Where is Animab headquartered?
Animab is headquartered in Gent, Belgium.
Which VCs invest in companies like Animab?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Animab's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Animab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.